EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Meningeal Solitary Fibrous Tumor: A Single-Center Retrospective Cohort Study

Siyer Roohani iD, Yasemin Alberti, Maximilian Mirwald iD, Felix Ehret, Carmen Stromberger, Soleiman Fabris Roohani, Katja Bender, Anne Flörcken, Sven Märdian, Daniel Zips, David Kaul

Sarcoma · 17.01.2024 · 2024 · 1-6

DOI: 10.1155/2024/8846018 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Sarcoma, erschienen am 17.01.2024. Verfasst von Siyer Roohani und 10 weiteren Autor:innen. Beteiligte Einrichtung: Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Charité – Universitätsmedizin Berlin, Berlin Institute of Health, Deutsche Forschungsgemeinschaft.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Meningeal solitary fibrous tumors (SFTs) are rare, malignant, mesenchymal tumors of the central nervous system. While surgical gross total resection is widely accepted as a positive prognostic factor for local control (LC), the role of postoperative radiotherapy (PORT) remains controversial. We sought to report our institutional experience with a particular focus on outcomes after PORT. Materials and Methods. In this single-center, retrospective cohort study, 20 patients with the primary diagnosis of histopathologically confirmed meningeal SFT were analyzed. Data on patient characteristics, imaging, treatment modalities, histopathology, and oncological outcomes were collected. LC and overall survival (OS) were assessed using the Kaplan–Meier estimator.

Results

The median follow-up time was 95.8 months. After surgery only, 9 out of 11 patients (81.8%) developed a local recurrence while, after surgery and PORT, 3 out of 9 patients (33.33%) showed local failure. The 5- and 10-year LC rates were 50.5% and 40.4% in the surgery-only group and 80% at both time points in the surgery with the PORT group. In the surgery-only group, 4 out of 11 patients (36.4%) died, and 4 out of 9 patients (44.4%) died in the surgery and PORT group. OS rates after 5 and 10 years were 88.9% and 66.7% in the surgery-only group and 88.9% and 76.2% in the surgery with PORT group.

Conclusions

Our findings suggest that PORT may improve LC in patients with meningeal SFT. The low incidence of meningeal SFT impedes prospective studies and requires further international collaborative efforts to exploit retrospective datasets and molecular analysis to improve patient outcomes.

Autor:innen und Institutionen

  • Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiation Oncology, Augustenburger Platz 1, Berlin 13353, Germany.
  • Berlin Institute of Health at Charité-Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Junior Clinician Scientist Program, Charitéplatz 1, Berlin 10117, Germany.
  • Charité-Universitätsmedizin Berlin, German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Berlin, Germany.
  • Department of Radiotherapy, West German Cancer Center, University of Duisburg-Essen, University Hospital Essen, Essen, Germany.
  • Vivantes Klinikum Neukölln, Department of Radiooncology and Radiotherapy, Berlin, Germany.
  • Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Department of Hematology, Oncology and Tumor Immunology, Augustenburger Platz 1, Berlin 13353, Germany.

ORCID-Profile: Siyer Roohani, Maximilian Mirwald

Förderung

  • Charité – Universitätsmedizin Berlin
  • Berlin Institute of Health
  • Deutsche Forschungsgemeinschaft
  • Projekt DEAL

Zitieren

APA

Roohani, S., Alberti, Y., Mirwald, M., Ehret, F., Stromberger, C., Roohani, S. F., Bender, K., Flörcken, A., Märdian, S., Zips, D., & Kaul, D. (2024). Meningeal Solitary Fibrous Tumor: A Single-Center Retrospective Cohort Study. Sarcoma, 2024, 1-6. https://doi.org/10.1155/2024/8846018

Vancouver

Roohani S, Alberti Y, Mirwald M, Ehret F, Stromberger C, Roohani SF, et al. Meningeal Solitary Fibrous Tumor: A Single-Center Retrospective Cohort Study. Sarcoma. 2024;2024:1-6. doi:10.1155/2024/8846018

BibTeX
@article{Roohani2024,
  author = {Roohani, Siyer and Alberti, Yasemin and Mirwald, Maximilian and Ehret, Felix and Stromberger, Carmen and Roohani, Soleiman Fabris and Bender, Katja and Flörcken, Anne and Märdian, Sven and Zips, Daniel and Kaul, David},
  title = {Meningeal Solitary Fibrous Tumor: A Single-Center Retrospective Cohort Study},
  journal = {Sarcoma},
  year = {2024},
  volume = {2024},
  pages = {1--6},
  doi = {10.1155/2024/8846018}
}
Kostenlos starten →